期刊文献+

硒代胱氨酸对人三阴性乳腺癌细胞的抑制作用 被引量:1

Inhibitory effect of selenocystine in human triple negative breast cancer cells
原文传递
导出
摘要 目的观察硒代胱氨酸(SeC)对三阴性乳腺癌(TNBC)的细胞毒效应,探讨其对TNBC的作用机制。方法选取3种TNBC细胞株,根据不同的实验条件,通过细胞计数试剂盒(CCK-8)法检测SeC对TNBC的抑制作用,通过膜联蛋白V-异硫氰酸荧光素(AnnexinV—FITC)法检测SeC对TNBC诱导凋亡的作用,通过碘化丙锭(PI)染色法检测SeC对TNBC细胞周期的影响。结果SeC对TNBC增殖有明显的抑制作用,该作用随着SeC浓度的升高或共培养时间延长而增强。SeC诱导TNBC发生明显细胞凋亡,同样与SeC存在时间-剂量关系。SeC还可以引起TNBC的S期比例增加,C2/M期比例减少,在20、40μmol/LSeC中尤为明显。10μmol/LSeC与MDA-MB-231共培养24、48、72h后发现:24、48、72h的S期比例与对照组比较有明显升高(P〈0.01);24h细胞凋亡率与对照组比较差异无统计学意义(P〉0.05),48h与72h细胞凋亡率明显升高(P〈0.01)。结论SeC对TNBC增殖有明显的抑制作用。SeC可以引起TNBC发生明显的S期细胞阻滞及细胞凋亡,并具有明显的时间一剂量效应。SeC诱导MDA—MB-231发生S期阻滞的时间较细胞凋亡早,提示SeC诱导的S期阻滞及细胞凋亡可能为SeC抗癌作用机制的序贯事件。 Objective The aim of this article is to observe the inhibitory effect of SeC for triplenegative breast cancer (TNBC) and investigate the mechanisms. Methods In this study TNBC cell lines were divided into three groups according to the type. Following the protocol, the ceils were incubated with different concentrations of SeC for different periods of time. The inhibitory effect of SeC on the growth of tumor cells was determined employing a cell counting kit-8 (CCK-8) assay. SeC induces cancer cells apoptosis examined by Annexin V-FITC assay. The influence of SeC on tumor cells cycle distribution detected through PI assay. Results SeC has the strongest inhibitory effect to TNBC in a time and dose-dependent manner. Apoptosis rates of TNBC are relative to SeC concentration and co-culture time. Along with the concentration of SeC elevating, proportion of S-phase raises and proportion of G2/M-phase decreases, especially in 20, 40 μmol/L SeC. After SeC culture with MDA-MB-231 in 24, 48 and 72 h, there were significant differences of S-phase proportion between experimental group and control group in 24, 48 and 72 h (P 〈 0.01 ). There were significant differences of apoptosis between experimental group and control group in 48 h and 72 h (P〈0. 01), but no difference in 24 h. Conclusion In vitro, SeC obviously inhibit the proliferation of TNBC in a time and dose-dependent manner, through the induction of S-phase arrest and apoptosis, S-phase arrest SeC induced MDA-MB-231 to is earlier than apoptosis. It implies that S-phase arrest and apoptosis are sequential evens of SeC to antitumor.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第10期1983-1985,共3页 Chinese Journal of Experimental Surgery
基金 广东省科技计划资助项目(20088030301128)
关键词 硒代胱氨酸 三阴性乳腺癌 S期阻滞 凋亡 Selenocystine Triple-negative breast cancer S-phase arrest Apoptosis
  • 相关文献

参考文献7

  • 1杨维良,张东伟.乳腺癌基因治疗的研究现状及展望[J].中华实验外科杂志,2005,22(5):633-635. 被引量:15
  • 2Tan DS,Marchlo C,Jones RL,et al? Triple negative breast cancer:mo-lecular profiling and prognostic impact in adjuvant anthracycline-trea-ted patients. Breast Cancer Res Treat,2008,111 :27-44.
  • 3Kassam S, Goenaga-lnfante H, Maharaj L, et al. Methylseleninic acidinhibits HDAC activity in diVuse large B-cell lymphoma cell lines.Cancer Chemother Pharmacol,2011,68:815-821.
  • 4Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T,et al. The aggresomepathway as a target for therapy in hematologic malignancies. Mol GenetMetab,2008,94 :283-286.
  • 5高玉霞,牛昀,丁秀敏,刘耀林,靳紫剑.中心体β-微管蛋白在乳腺癌前病变及其乳腺癌中的表达和意义[J].中华实验外科杂志,2008,25(1):18-20. 被引量:3
  • 6Antony ML,Singh SV. Molecular mechanisms and targets of cancerchemoprevention by garlic-derived bioactive compound diallyl trisul-fide. Indian J Exp Biol,2011,49:805-816.
  • 7Toogood PL, Progress toward the development of agents to modulate thecell cycle. Curr Opin Chem Biol ,2002,6,472-478.

二级参考文献31

  • 1陈剑英,张波,王国斌,郑海,陈庆勇,陈道达.人类乳腺癌基因表达分析[J].中华实验外科杂志,2005,22(4):429-431. 被引量:15
  • 2Lingle WL, Barrett SL, Negron VC, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci ,2002,99 : 1978-1983.
  • 3Yang SB,Zhou XB, Zhu HX, et al. Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma. Oncol Rep, 2007,17 : 1083 -1088.
  • 4Yamamoto Y, Matsuyama H, Chochi Y, et al. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet Cytogenet,2007,174:42-47.
  • 5Fukasawa K. Centrosome amplification, chromosome instability and cancer development. Cancer Lett,2005,230:6-19.
  • 6Tavassoli FA, Devilee P. The WHO classification of tumors of the breast and female genital organs. Lyon:IARC Press,2003.10-112.
  • 7Tanaka K,Iwamoto S,Gon G,et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 2000,6:127-134.
  • 8Storehova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol,2004,5:45-54.
  • 9Salisbury JL, D' Assoro AB, Lingle WL. Centrosome amplification and the origin of chromosomal instability in breast cancer. J Mammary Gland Biol Neoplasia,2004,9:275-283.
  • 10Ran J. Targeting actin remodeling profiles for the detection and management of urothelial cancers a perspective for bladder cancer research. Front Biosci ,2002,7 : 1-8.

共引文献16

同被引文献9

  • 1Chen TF,Zheng WJ,Wong YS. Mitochondria-me-diated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative[J].Biomedicine and Pharmacotherapy,2008,(02):77-84.
  • 2Hu H,Li GX,Wang L. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin[J].Clinical Cancer Research,2008,(04):1150-1158.doi:10.1158/1078-0432.CCR-07-4037.
  • 3Cleator S,Heller W,Coombes RC. Triple negative breast cancer:therapeutic options[J].Lancet Oncology,2007,(03):235-244.
  • 4Rakha EA,Ellis IO. Triple-negative/basal-like breast cancer:review[J].Pathology,2009,(01):40-47.
  • 5Dent R,Trudeau M,Pritchard KI. Triple negative breast cancer:clinical features and patterns of recurrence[J].Clinical Cancer Research,2007,(15):4429-4434.
  • 6Huang H,Jiang Z,Wang T. Single-agent capeci-tabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metasta-tic breast cancer[J].Anti-Cancer Drug Design,2012,(07):718-723.
  • 7Hoefig CS,Renko K,K(o)hrle J. Comparison of different selenocompounds with respect to nutritional value vs.toxicity using liver cells in culture[J].Journal of Nutritional Biochemistry,2011,(10):945-955.
  • 8Chintala S,Tóth K,Cao S. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α[J].Cancer Chemotherapy and Pharmacology,2010,(05):899-911.
  • 9蒋光愉,李红,何伟丽,王宁霞.三阴型乳腺癌FOXA1和BRCA1的表达及其对预后的意义[J].中国病理生理杂志,2012,28(7):1230-1234. 被引量:12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部